This video is the third in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the ...

A sneak preview for the final installment of our webinar series, "The future of life sciences in Canada".

Life sciences is one of the most heavily regulated industries in Canada, and with this regulatory environment come administrative and constitutional challenges.

This video is the third in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the federal and provincial...

What challenges and opportunities exist in the public procurement of pharmaceutical products and medical devices by hospitals, health authorities and group procurement organizations?

The 2020 U.S. election is historic for many reasons—and the outcome will no doubt have a broad and lasting impact on how business gets done between the United States and Canada.

Senior associate Chris Hunter sat down with the Annual Review of Insolvency Law Society to share his insight in its ARIL Podcast Program.

In Wiener Städtische Versicherung AG v. Infrassure Ltd, 2023 ONSC 5256, the Ontario Superior Court of Justice (Commercial List) ordered a reinsurer to follow the settlement of a claim by a lead insurer...

The Canadian Intellectual Property Office (CIPO) Canada is introducing significant government fee increases (in most cases by approximately 25%, with some exceptions) on January 1, 2024.

Amid this year's disruptions to IP litigation, we have seen high-impact developments affecting life sciences companies.

What is a divisional patent application? Should inventors be engaged in the patent application process?

Last week, we wrote about the Federal Court's latest judicial review which sheds light on how courts may view eligibility of patents for Canada's recently introduced Certificates of Supplementary Protection (CSPs).

What does a new ruling on Canada's equivalent to patent term extension mean for the pharmaceutical industry?

Andrew approaches the question from the discussion point of whether law is a profession or a trade.

Partners Jeremy Opolsky and Sarah Whitmore and associate Adrienne Oake have authored an article for The Lawyer's Daily.

The future of life sciences in Canada

In this video, Sylvie Rodrigue, Ad. E., and Suzie Cloutier share the latest class action trends in Québec, including: Areas of focus for plaintiffs, such as the very recent rise of class actions against online platforms...

Uncertainties currently abound in many sectors and commercial real estate is no exception. While the COVID-19 pandemic has caused some level of distress in certain sectors of the ...

Join our real estate and insolvency lawyers as they discuss their perspective on the current state of the office, retail and mixed-use real estate market as well as redevelopment projects

In a surprising development, as part of the reaction to the proposed merger of the U.S. Professional Golfers' Association and LIV Golf professional golf tours, Senator Ron Wyden, the Chairman...